Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 10, 2026	Kinaset Therapeutics	$103.0M Series B	Anand Mehra, Henry Stusnick	5AM Ventures, Atlas Venture, Bram Vanparys, PhD, MBA, Daniela Begolo, Pictet Alternative Advisors, Schroders Capital, Sixty Degree Capital, Vivo Capital, Willett Advisors
Jan 1, 2024	OnCusp Therapeutics	$100.0M Series A	Novo Ventures, OrbiMed, Chong Xu	F-Prime Capital Partners, Blackbird BioVentures, Catalio Capital Management, Marshall Wace, Sofinnova Ventures
Nov 1, 2022	Escient Pharmaceuticals	$120.0M Series C	Abingworth, Forge Life Science Partners, NEA	5AM Ventures, Access Biotechnology, Atlas Venture, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, Sanofi Ventures, The Column Group, Altitude Life Science Ventures, Avego Bioscience Capital, Cowen Healthcare Investments, PFM Health Sciences, Redmile Group, The Eleven Fund

Financial History

Leadership Team